| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.9468951181327584 2.2191288765022708 0.0264779580152461 0.9999998897354128 1.0 4 P07099 1 |
| Vitamin a and carotenoid metabolism 0.8386310620556781 2.1521532186799885 0.0313852887698846 0.9999999946026163 1.0 5 Q8WTV0,O94788 2 |
| Striated muscle contraction pathway 0.810836305788077 2.0371421546741577 0.041635798585466 0.9999999999905864 1.0 5 P09493,P08670,P06753 3 |
| Tlr4 signaling and tolerance 0.7601006839903569 1.8236906426162849 0.0681988543071108 1.0 1.0 5 Q15629 1 |
| Familial partial lipodystrophy fpld 0.7202779833534978 1.6670708823788776 0.0955003111860639 1.0 1.0 7 O60725 1 |
| Antiviral and antiinflammatory effects of nrf2 on sarscov2 pathway 0.7230088138537489 1.6649914960784826 0.0959144524309203 1.0 1.0 5 P09601 1 |
| Oxidation by cytochrome p450 0.7180895628493648 1.643793402972089 0.1002188845194553 1.0 1.0 5 O43169,Q16850 2 |
| Rala downstream regulated genes 0.7076781621711191 1.6300371187568687 0.1030936521807952 1.0 1.0 6 Q96KP1,P16989 2 |
| Folate metabolism 0.7355214692542384 1.6129203195756645 0.1067618200043234 1.0 1.0 14 P00374 1 |
| Neuroinflammation 0.8477905374718828 1.5934932157526962 0.1110495890654976 1.0 1.0 3 O15111 1 |
| Glycerophospholipid biosynthetic pathway 0.7006170447519069 1.5820047514098217 0.113648485808576 1.0 1.0 7 O00116,Q9HCL2,O95674 3 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6958247683861118 1.5785744576941094 0.1144336971703745 1.0 1.0 6 Q15392,Q16850 2 |
| Proteoglycan biosynthesis 0.7748344370860877 1.5547514332691657 0.1200052799370949 1.0 1.0 4 O95340,Q8TB61,Q96L58 3 |
| Ethanol effects on histone modifications 0.710083121556766 1.5373422081285697 0.1242095305491264 1.0 1.0 12 P00374 1 |
| Histone modifications 0.6885629316494447 1.4780878232218344 0.1393842729012486 1.0 1.0 10 Q9H7B4 1 |
| Progeriaassociated lipodystrophy 0.6754034314572479 1.4378279996448324 0.150482862759707 1.0 1.0 9 O60725 1 |
| Reninangiotensinaldosterone system raas 0.8063269490347376 1.433649213030186 0.1516723920417233 1.0 1.0 3 P0DP25 1 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.6538585718651716 1.394942927147075 0.1630330508350852 1.0 1.0 6 Q9Y6K9,Q7Z434,O15111 3 |
| Nanomaterial induced apoptosis 0.7338281497729154 1.3916577821681946 0.1640260523553527 1.0 1.0 4 O43464,O95831 2 |
| Cellular proteostasis 0.733112582781449 1.3888030960322078 0.1648926335495164 1.0 1.0 4 Q9UHV9,O15212,P61758 3 |
| Eicosanoid metabolism via lipooxygenases lox 0.6467477670923901 1.363647016680687 0.1726786869446013 1.0 1.0 6 Q14914,Q8N8N7 2 |
| T cell receptor and costimulatory signaling 0.7179554015179115 1.3282919391184322 0.184081681666973 1.0 1.0 4 P19174 1 |
| Influence of laminopathies on wnt signaling 0.6467062573154362 1.31226673208887 0.1894301528444004 1.0 1.0 9 O75844,O60725,P50402 3 |
| Ketogenesis and ketolysis 0.6215956378214265 1.2526708537855098 0.2103255173274931 1.0 1.0 6 O43772 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.6905726087928831 1.218884755760634 0.2228879363813809 1.0 1.0 4 Q15185,O00170 2 |
| Sting pathway in kawasakilike disease and covid19 0.7487586891757687 1.2112102840634935 0.2258148223115084 1.0 1.0 3 Q86UT6,O15111 2 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.6125310236334313 1.183261499792416 0.2367055261108572 1.0 1.0 5 O15111,P06753 2 |
| Eicosanoid metabolism via cyclooxygenases cox 0.5957134991881932 1.1382622504042703 0.2550109918986487 1.0 1.0 6 Q14914,Q8N8N7 2 |
| Kennedy pathway from sphingolipids 0.7291289942724785 1.135642167334047 0.2561063535587149 1.0 1.0 3 P35790 1 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.7272426348891131 1.1283971484512294 0.2591522315312167 1.0 1.0 3 Q9Y6K9,O15111 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.7262495862297287 1.124584512499056 0.2607651396193517 1.0 1.0 3 Q9Y6K9,O15111 2 |
| Resistin as a regulator of inflammation 0.5715731548013022 1.0317106687146809 0.302207678036209 1.0 1.0 6 P19174,Q9Y6K9,O15111 3 |
| Mirnas involvement in the immune response in sepsis 0.7004303210857332 1.0258707772677538 0.3049524987615852 1.0 1.0 3 Q9Y6K9,O15111 2 |
| Methionine de novo and salvage pathway 0.5735411119765861 1.0075185817288876 0.3136856327779649 1.0 1.0 8 Q13126 1 |
| Cytosolic dnasensing pathway 0.5869077051097288 1.0012332213304331 0.3167140689426966 1.0 1.0 12 O15111,Q7Z434,Q86UT6,O15160,Q9Y6K9 5 |
| Mthfr deficiency 0.5658191917527323 0.9899920619885756 0.3221779989837023 1.0 1.0 7 P21964,P35790 2 |
| Nephrogenesis 0.824619457313042 0.9701561756992452 0.3319686514177902 1.0 1.0 2 O94788 1 |
| Tolllike receptor signaling related to myd88 0.6182707183319778 0.9320299792322722 0.3513210324433908 1.0 1.0 4 Q9Y6K9,O15111 2 |
| Estrogen receptor pathway 0.6691887745095955 0.907926174458911 0.3639172276331073 1.0 1.0 3 Q9HCL2 1 |
| Allograft rejection 0.5534069250403146 0.9036800438376033 0.3661650839239088 1.0 1.0 9 P08670,Q9BY49,P49327,P10321 4 |
| Preimplantation embryo 0.5388497335753304 0.8723420754446158 0.3830217903308779 1.0 1.0 7 P17096,Q99729 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.6583596377697467 0.8675727541844513 0.3856282672404398 1.0 1.0 3 Q7Z434 1 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5603306668321171 0.8554673422073871 0.3922924764613655 1.0 1.0 14 O75844,P55209,P48729,O60725,P50402 5 |
| Mecp2 and associated rett syndrome 0.5698899596803578 0.8504341340330293 0.3950837653816097 1.0 1.0 17 P35637,P67809,P31943 3 |
| Apoptosis modulation by hsp70 0.6536576897108326 0.8501545800855621 0.3952391500365957 1.0 1.0 3 O95831 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5522717393105296 0.8212067640811832 0.4115285043236665 1.0 1.0 14 O75821,P55010,P55884 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.5510090389477648 0.8158552158977772 0.4145829485758439 1.0 1.0 14 O43772,Q9BY49,P11310 3 |
| Disruption of postsynaptic signaling by cnv 0.5232676006256637 0.7742543708883273 0.4387803811530526 1.0 1.0 9 Q06787,Q7L576,Q14168,Q13555 4 |
| Vasopressinregulated water reabsorption 0.5473327170931754 0.7556712144420887 0.4498463468466451 1.0 1.0 17 Q9UJW0 1 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.5139561902061878 0.7500006732882849 0.4532542992492283 1.0 1.0 8 O14964,P61020,P31943 3 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.5377199196138387 0.7450272835655046 0.4562552263156141 1.0 1.0 15 P08670,P05067,P04792,P16989 4 |
| Canonical and noncanonical notch signaling 0.7584381204500363 0.7325634922637598 0.4638247045516679 1.0 1.0 2 O15111 1 |
| Canonical nfkb pathway 0.7485109199205859 0.6984840099263616 0.4848745543288899 1.0 1.0 2 O15111 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.7485109199205859 0.6984840099263616 0.4848745543288899 1.0 1.0 2 O15111 1 |
| Nodlike receptor nlr signaling pathway 0.7485109199205859 0.6984840099263616 0.4848745543288899 1.0 1.0 2 O15111 1 |
| Copper homeostasis 0.4912101345700071 0.6632702148924621 0.5071575090037834 1.0 1.0 5 P05067 1 |
| Angiogenesis 0.727001985440112 0.6264559254876 0.5310159372222758 1.0 1.0 2 P19174 1 |
| Sars coronavirus and innate immunity 0.7250165453342212 0.6199428783894785 0.5352953946398817 1.0 1.0 2 Q7Z434 1 |
| Sterol regulatory elementbinding proteins srebp signaling 0.5345436075246301 0.5920850094460934 0.5537936645752157 1.0 1.0 25 P55735,Q8WTV0 2 |
| Pparalpha pathway 0.4687497883327201 0.5774372571321142 0.5636441119308797 1.0 1.0 7 P11310 1 |
| Lung fibrosis 0.4628170460936729 0.5676832699126765 0.5702500536337389 1.0 1.0 6 P09601 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.4625390706040462 0.5250358278279639 0.5995582848648422 1.0 1.0 9 P50570,Q9NR77,P04792 3 |
| Metapathway biotransformation phase i and ii 0.5029568048231154 0.522275024393736 0.6014788560823958 1.0 1.0 21 P21964,Q7LGA3,Q86UY6,P07099 4 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.4479482337856336 0.4818797157264177 0.6298913964503468 1.0 1.0 8 P19174,Q07157,Q15746 3 |
| 1q211 copy number variation syndrome 0.4336383089621356 0.4406943856753874 0.6594342616328457 1.0 1.0 7 Q9NPH0,Q9UDY2 2 |
| Erk pathway in huntingtons disease 0.6551952349437519 0.40891104375381 0.6826049441028967 1.0 1.0 2 P28482 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4660045304797309 0.3865073644620153 0.6991209495171191 1.0 1.0 21 Q15392,Q9BWD1,Q16850 3 |
| Transcription cofactors ski and skil protein partners 0.414844237713157 0.3741045071117075 0.708326565584632 1.0 1.0 5 Q9UPW6 1 |
| Ccl18 signaling pathway 0.4156006733338444 0.3510717764562825 0.7255345011094354 1.0 1.0 9 P33176,Q86UE4,P00403,P08670,P07196 5 |
| Constitutive androstane receptor pathway 0.4044385558132009 0.3392481642206567 0.7344227884674928 1.0 1.0 5 Q99615,Q14683,P07900,Q15257 4 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4041073203047494 0.3381610898191627 0.7352417961981892 1.0 1.0 5 P49770,P05556,Q13418,P42345 4 |
| Tryptophan metabolism 0.4306227792321058 0.3335865030265919 0.7386916044361289 1.0 1.0 15 Q15392 1 |
| Eicosanoid synthesis 0.6148246194573203 0.3065381428549793 0.7591949428544391 1.0 1.0 2 Q9H7Z7 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.4809665673618046 0.2954177918993256 0.76767474351226 1.0 1.0 3 Q9NWH9,P42345 2 |
| Nocgmppkg mediated neuroprotection 0.3856664378898637 0.2739519959781857 0.784121512451041 1.0 1.0 7 Q99996,P30536,Q13555 3 |
| Nephrotic syndrome 0.3977720430503915 0.2596604362289769 0.7951257133526852 1.0 1.0 12 P11047,O75844,Q14108,P35579,O43707,Q9NQW6 6 |
| 15q112 copy number variation syndrome 0.4213234102056102 0.258770448667507 0.7958123599740621 1.0 1.0 4 Q06787,Q7L576 2 |
| Endothelin pathways 0.3867374973827311 0.2564043754132703 0.7976386096715604 1.0 1.0 9 P42892,Q15746 2 |
| Sphingolipid metabolism integrated pathway 0.3759354637882354 0.2512373111429861 0.8016306393151829 1.0 1.0 5 O15270,O95470 2 |
| Sphingolipid metabolism overview 0.3759354637882354 0.2512373111429861 0.8016306393151829 1.0 1.0 5 O15270,O95470 2 |
| Fatty acid betaoxidation 0.4125550489768567 0.2345296841639215 0.814573791070591 1.0 1.0 19 O43772 1 |
| Ovarian infertility 0.4531612048990386 0.2311983486184681 0.8171607128668688 1.0 1.0 3 O75376,P11802 2 |
| Splicing factor nova regulated synaptic proteins 0.3933888737004731 0.2265769837552461 0.820752691164782 1.0 1.0 14 Q9BY67,Q9UNS2,Q13555,Q9UBB6 4 |
| Novel intracellular components of rigilike receptor rlr pathway 0.3818161405229217 0.2217556174626553 0.824504131341516 1.0 1.0 11 Q86UT6,Q7Z434,O15111,O00571 4 |
| Myometrial relaxation and contraction pathways 0.410071121074593 0.2177708335605196 0.8276076706200954 1.0 1.0 20 P27348,Q05655,Q13555,Q9Y3B8,P0DP25,P19174,P31946 7 |
| Pregnane x receptor pathway 0.4043046357615734 0.2172839309432877 0.8279870792090118 1.0 1.0 4 Q99615,P62195,P07900 3 |
| Primary focal segmental glomerulosclerosis fsgs 0.3939441480873119 0.1909703513721714 0.8485488218161881 1.0 1.0 18 P19174,P08670,P27348 3 |
| Adipogenesis 0.3868851306723387 0.1896143168634305 0.8496113675084973 1.0 1.0 16 P43490,O75844,P17096 3 |
| Mitochondrial complex iii assembly 0.3656898867183604 0.1857504407717908 0.8526404705748654 1.0 1.0 10 Q6DKK2,Q9UDW1 2 |
| Dna mismatch repair 0.3916356977655467 0.1847121251167352 0.8534548353616782 1.0 1.0 18 Q9UQ84 1 |
| Interactions between loxl4 and oxidative stress pathway 0.4187355180403777 0.1651341551454925 0.8688383901196803 1.0 1.0 3 Q16543,Q9BQ95 2 |
| Sulfation biotransformation reaction 0.3798578662679713 0.1646472862736201 0.869221610026155 1.0 1.0 4 O95340 1 |
| Translation factors 0.4413461693526699 0.1460897745362568 0.8838505185509531 1.0 1.0 38 P23588,P55010,O75821,P49770,Q15056,P29692,P55884,P60228,O75153 9 |
| Srebf and mir33 in cholesterol and lipid homeostasis 0.4064879179079701 0.1453470502054839 0.8844368684161696 1.0 1.0 3 P49327,P42345 2 |
| Bdnftrkb signaling 0.3373921899448153 0.1309307014623372 0.8958301274816298 1.0 1.0 8 P19174,Q15418,P62993 3 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3592715231787975 0.1269689917899361 0.8989649408489049 1.0 1.0 4 P28482,P42345,Q13283 3 |
| Type ii diabetes mellitus 0.3580909963802806 0.1249952731403786 0.9005272924792378 1.0 1.0 4 Q05655 1 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.3236170917522404 0.1230713458088436 0.9020506014857248 1.0 1.0 5 P55263,Q99707,P32929,P23526 4 |
| Ebsteinbarr virus lmp1 signaling 0.3228720109429556 0.1215881136605502 0.90322522756462 1.0 1.0 5 Q9Y6K9,O15111 2 |
| Hedgehog signaling pathway wp4249 0.3896293664047332 0.1212936037800474 0.9034584860587148 1.0 1.0 3 P48729 1 |
| Onecarbon metabolism and related pathways 0.3526935207335059 0.1205109406959046 0.9040784133861954 1.0 1.0 14 O43865,P32929,P35790 3 |
| Complement system 0.3338050044387658 0.115192350941194 0.9082926613831912 1.0 1.0 9 P11047,Q07021 2 |
| Immune response to tuberculosis 0.4887491727333002 0.1035571161157958 0.9175208209995652 1.0 1.0 2 P42224 1 |
| Ferroptosis 0.3737164575501452 0.1016271649908446 0.9190526165334312 1.0 1.0 23 P45880,P09601,P04792,P16435 4 |
| Glycogen synthesis and degradation 0.3468493165496893 0.1004367073264335 0.9199976288558048 1.0 1.0 15 P0DP25 1 |
| Mechanoregulation and pathology of yaptaz via hippo and nonhippo mechanisms 0.3191912495856782 0.0980697528529727 0.9218769054469886 1.0 1.0 7 P05556,P35222,P27348,Q13177,Q16512,P35221 6 |
| Sudden infant death syndrome sids susceptibility pathways 0.3668658805907673 0.0806357638942177 0.9357316233265948 1.0 1.0 24 P42892,P67809,P11310 3 |
| Hostpathogen interaction of human coronaviruses autophagy 0.3221854304635714 0.0745210053826488 0.9405958277573224 1.0 1.0 4 O95352,Q99570,P42345 3 |
| Male infertility 0.3497317434601756 0.0547176092820887 0.9563634402007644 1.0 1.0 23 Q15165 1 |
| Type ii interferon signaling ifng 0.2922465208747481 0.0543141066249058 0.9566849106821677 1.0 1.0 6 P42224,Q05655,P62805,P19525,P01889 5 |
| Heart development 0.29195630585898 0.0454312188952752 0.9637635975897376 1.0 1.0 3 P35222,P28482 2 |
| Relationship between inflammation cox2 and egfr 0.2917218543046225 0.0453528593175384 0.9638260551089344 1.0 1.0 4 P28482,P31751,Q9H7Z7 3 |
| Bile acids synthesis and enterohepatic circulation 0.2916252896391856 0.0453195971316753 0.9638525672333268 1.0 1.0 3 P28482,P51114 2 |
| Cannabinoid receptor signaling 0.291625289639184 0.0453195971316747 0.9638525672333272 1.0 1.0 3 P28482,P10644 2 |
| Neovascularisation processes 0.2915287888815438 0.0447881618687046 0.9642761610850712 1.0 1.0 2 P28482 1 |
| Osteoblast differentiation and related diseases 0.2921087533156538 0.0432934536545333 0.9654676095583876 1.0 1.0 8 P42224,P35222,P78527,Q05655,O00443,Q99570,P28482 7 |
| Cytosine methylation 0.2634587989914054 0.0344845084234409 0.9724907954887824 1.0 1.0 5 P48735 1 |
| Kallmann syndrome 0.2662251655629053 0.029186528276523 0.976715825535641 1.0 1.0 4 P28482,Q06124,P62993 3 |
| Proximal tubule transport 0.2821618037135273 0.0289557095201839 0.9768999144512928 1.0 1.0 8 Q9UI12,P08195,Q9Y5K8,P08183,P21283,P05023,P36543 7 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.2945455718182972 0.0268188385314442 0.9786042276464038 1.0 1.0 12 O15111,P62993,O95433,P19174,P11802 5 |
| Modulators of tcr signaling and t cell activation 0.292908455377511 0.0245978717843352 0.9803757168573656 1.0 1.0 12 P19174,O15111,O95376 3 |
| Mitochondrial complex iv assembly 0.2921097400169147 0.0235305567701889 0.9812270644506684 1.0 1.0 12 P00403,Q9Y6N1,P14406 3 |
| G1 to s cell cycle control 0.3327590876305457 0.0222585929167874 0.9822416787570618 1.0 1.0 24 Q07864,P25205,Q9Y619,P49643,Q14566,Q13416,P11802 7 |
| Ranklrank signaling pathway 0.2968146732975814 0.0204899131369766 0.983652558539362 1.0 1.0 14 O95340,P19174 2 |
| Tcell receptor tcr signaling pathway 0.3058817863040183 0.0185999309439074 0.9851602579259644 1.0 1.0 17 O15111,P62993,Q05655,P49327,Q9Y6K9,P19174,P08670 7 |
| Sarscov2 innate immunity evasion and cellspecific immune response 0.2729899546029646 0.0089069434331204 0.9928933813165493 1.0 1.0 10 Q7Z434 1 |
|
|
